Transmed SpA was established in Milan on 12 September 2005. It is a joint company with equal shareholding of the Italian company SeaCorridor (a joint governance company Eni and Snam) and the Algerian company Sonatrach.
In this section, all Urgent Market Messages (UMMs) are reported as required by EU regulation [Regulation (EU) No. 1227/2011 (REMIT)] concerning information transparency.
10/29/2025
Transmed is pleased to inform that, following a successful trial period for the Modulation Service (“MS”),...
06/30/2025
TRANSMED First Come First Served Offer 2025-26
(hereinafter the “Offer”)
TRANSMED informs that the firm transportation capac...
05/26/2025
Transmed is pleased to inform that it is introducing a new Modulation Service (“MS”), aimed at providing Shippers with additional balan...